2 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
Follow Wasting Syndrome: new trials by email Literature Review of Wasting Syndrome trials Research Report on Wasting Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Inspiratory Flow Rates Achieved by the COPD Patients Through Breezhaler®, Ellipta® and Handihaler® Inhaler Devices Breezhaler®, Ellipta®, Handihaler® - Pulmonary Disease, Chronic Obstructive (COPD) | Phase 4 | Completed | Novartis Pharmaceuticals | 97 | 2015-12-16 | 2018-06-26 |
| Nutrition Intervention in AIDS Wasting oxandrolone, Progressive Resistance Training - HIV Wasting Syndrome | Phase 4 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1998-01-01 | 2010-01-13 |
HIV Wasting Syndrome (1) · Lung Diseases (1) · Motor Activity (1) · Muscular Atrophy (1) · Pulmonary Disease, Chronic Obstructive (1) · Weight Loss (1)
Metabolic Diseases (2) · Nutrition Disorders (2) · Nutritional and Metabolic Diseases (2) · Atrophy (1) · Behavior (1) · Blood-Borne Infections (1) · Body Weight (1) · Body Weight Changes (1) · Chronic Disease (1) · Communicable Diseases (1) · Disease Attributes (1) · Genital Diseases (1) · HIV Infections (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1)
Oxandrolone (1)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · Novartis Pharmaceuticals (1)
Argentina (1) · United States (1)
Abby Shevitz, MD (1) · Sherwood Gorbach, MD (1)